Immunotherapy for Colorectal Cancer

The recent success of anti-PD1 drugs in metastatic colorectal cancer patients with mismatch repair deficiency generated overwhelming enthusiasm for immunotherapy in the disease. However, patients with mismatch repair deficient colorectal cancer represent only a small subset of the metastatic populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Boland, Patrick M., Ma, Wen Wee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447960/
https://www.ncbi.nlm.nih.gov/pubmed/28492495
http://dx.doi.org/10.3390/cancers9050050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447960/
https://www.ncbi.nlm.nih.gov/pubmed/28492495
http://dx.doi.org/10.3390/cancers9050050

Ejemplares similares